23andMe’s Genetic Data Trove Rests on Professor as Protector (1)

May 22, 2025, 4:15 PM UTCUpdated: May 22, 2025, 6:01 PM UTC

A crucial step in handling the sale of genetic data from over 15 million 23andMe customers now rests largely in the hands of a law professor.

The May 19 announcement that Regeneron Pharmaceuticals Inc. will buy most of the assets of the bankrupt genetic testing provider started a countdown for Washington University School of Law professor Neil Richards, the court-appointed privacy ombudsman, to investigate the company’s privacy policies.

In a report due before June 10, he’ll recommend to the judge whether—and how—the sale of data should take place, highlight any necessary changes to mitigate consumer harm, and evaluate Regeneron’s ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.